Departments
Radiation Oncology
Radiation Oncology
External radiotherapy
Volumetric Modulated Arc Therapy (VMAT)
Image Guided Radiation Therapy (IGRT)
Intensity Modulated Radiation Therapy (IMRT)
Stereotactic Radiation Therapy (SRT)
Stereotactic Radio Surgery (SRS)
Stereotactic Body Radiation Therapy (SBRT)
Three-Dimensional Conformal Radiation Therapy (3-D CRT)
Respiratory Gating
Internal Radiotherapy
Remote After Loading High Dose Rate Brachytherapy (HDR Brachytherapy)
Medical Oncology
Medical Oncology
Chemotherapy
Hormonal Therapy
Immunotherapy / Biological Therapy
Targeted Therapy
Neutropenic Care
Nutritional Therapy
Surgical Oncology
Surgical Oncology
Neuro Oncology
Head and Neck Oncology
Breast Oncology
Thoracic Oncology
Gynaec Oncology
Cosmetic and Reconstructive Surgery
G. I. Oncology
Uro Oncology
Musculo-skeletal Oncology
Gynaec Oncology
Gynaec Oncology
Cancer of Cervix
Cancer of Ovary and Fallopian Tube
Cancer of Uterine Cavity
Cancer of Vulva
Cancer of vagina
Cancer of Persistent Gestational Trophoblastic Tumor (GTNs)
Anesthesiology & Critical
Radiology & Imaging
Pathology & Transfusion
Pathology & Transfusion
Histopathology
Cytopathology
Haematology
Biochemistry
Serology
Clinical Pathology
Microbiology
Transfusion Medicine
Emergency Services
Nursing Services
Our Doctors

- Featured Doctors in Popular Specialties.... ........ Read more
Research & Training
Cancer research trials are carried out to try to find new and better treatments for cancer. Trials that are carried out on patients are known as clinical trials. When radiotherapy is a part of a clinical trial and it is explained to the patients and their family. There can be many benefits in being a part of a treatment research trial. Trials help to improve knowledge about cancer and the development of new treatments. Patients are also carefully monitored during and after the study.Following trials are currently under progress in the department:
- A randomized controlled comparative trial to evaluate the efficacy and safety of 2-Deoxy-D-Glucose (2 DG) as a radiomodifier in the treatment of Glioblastoma Multiformae.
- An open label, prospective, multicentic study to evaluate the safety and efficacy of BIOMab-EGFR (NIMOTUZUMAB) as induction and maintenance therapy in combination with Radiotherapy plus temozolamide ( concomitant & adjuvant) in Indian patients with Glioblastoma Multiformae.
Research and teaching are strong points of DHRC as it not only conducts post-graduate and and post post-graduate courses viz, DNB in Radiation, Medical and Surgical Oncology, but it also imparts training to residents and paramedicals who form the support system to this tertiary care center.
Various research projects are taken not only related to clinical subjects but also drug trials, biogenetics and oncopathology.
Consultants and trainees are encouraged to attend various conferences and workshops to keep them abreast of latest happenings in the field.
All research projects are under the surveillance of the ethics committee and director-academics.
All doctors, nurses and technicians are regularly put through training by the academic staff as a part of the training calendar of different departments.
- Diseases Treated
- Infrastructure
- Information
- Research & Training

Follow us on